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nternalization of 
 
 
 
-adrenergic receptors (
 
 
 
ARs) occurs
by the sequential binding of 
 
 
 
-arrestin, the clathrin
adaptor AP-2, and clathrin. D-3 phosphoinositides,
generated by the action of phosphoinositide 3-kinase
(PI3K) may regulate the endocytic process; however, the
precise molecular mechanism is unknown. Here we
demonstrate that 
 
 
 
ARKinase1 directly interacts with the
PIK domain of PI3K to form a cytosolic complex. Over-
expression of the PIK domain displaces endogenous PI3K
from 
 
 
 
ARK1 and prevents 
 
 
 
ARK1-mediated translocation
of PI3K to activated 
 
 
 
2
 
ARs. Furthermore, disruption of the
 
 
 
ARK1/PI3K interaction inhibits agonist-stimulated AP-2
I
 
adaptor protein recruitment to the 
 
 
 
2
 
AR and receptor
endocytosis without affecting the internalization of other
clathrin dependent processes such as internalization of
the transferrin receptor. In contrast, AP-2 recruitment is
enhanced in the presence of D-3 phospholipids, and receptor
internalization is blocked in presence of the speciﬁc phos-
phatidylinositol-3,4,5-trisphosphate lipid phosphatase PTEN.
These ﬁndings provide a molecular mechanism for the
agonist-dependent recruitment of PI3K to 
 
 
 
ARs, and support
a role for the localized generation of D-3 phosphoinositides
in regulating the recruitment of the receptor/cargo to clathrin-
coated pits.
 
Introduction
 
 
 
-Adrenergic receptors (
 
 
 
ARs)* are a member of the large
family of G protein–coupled receptors (GPCRs) (Johnson,
1998; Rockman et al., 2002). In the heart, ligand activation
of 
 
 
 
ARs results in the dissociation of the cognate heterotrimeric
GTP binding protein (G-protein) into G
 
 
 
 and G
 
  
 
 sub-
units, leading to stimulation of the effector adenylyl cyclase
and subsequent physiologic response (Koch et al., 2000).
Exposure to agonist also promotes the rapid desensitization
of 
 
 
 
ARs, that not only leads to the attenuation of signaling,
but also targets the activated receptor to clathrin-coated pits for
internalization (Ferguson et al., 1996; Goodman et al., 1996).
An early step in this process involves the rapid phosphorylation
of agonist-occupied receptors by a G protein–coupled receptor
kinase (GRK, commonly known as the 
 
 
 
-adrenergic receptor
kinase or 
 
 
 
ARK) (Lefkowitz, 1998). The phosphorylation
of activated 
 
 
 
ARs by 
 
 
 
ARK1 requires translocation of the
primarily cytosolic 
 
 
 
ARK to the plasma membrane, a process
facilitated by the liberated G
 
  
 
 subunits and membrane
phospholipids (Pitcher et al., 1998). The second step involves
binding of the protein 
 
 
 
-arrestin to the phosphorylated
receptor resulting in termination of the signal (Lefkowitz,
1998). The binding of 
 
 
 
-arrestin serves to target phosphory-
lated 
 
 
 
ARs for internalization, through the recruitment of the
AP-2 adaptor protein and clathrin to the receptor complex
(Laporte et al., 2000). There is increasing evidence that
phosphatidylinositol (PtdIns) phospholipids are important
molecules in endocytosis of membrane proteins (Czech,
2000). Because a key enzyme for the generation of phospho-
lipids is phosphoinositide 3-kinase (PI3K), it suggests a possible
role for PI3K in the internalization of GPCRs. Thus, although
the endocytic process is a multistep event involving the
coordinate interaction between proteins and as well as the
control of lipid modification, the precise molecular mechanisms
for this interaction are not well understood.
PI3Ks are a conserved family of lipid kinases that catalyze
the addition of phosphate on the third position of the inositol
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ring (Rameh and Cantley, 1999). Stimulation of a variety of
receptor tyrosine kinases and GPCRs results in the activation
of PI3K and leads to an increase in the level of D-3 PtdIns,
which in turn are potent signaling molecules that modulate a
number of diverse cellular effects including: cell proliferation,
cell survival, cytoskeletal rearrangements, and receptor en-
docytosis (Martin, 1998; Sato et al., 2001). In this context,
GPCR stimulation leads to the activation of the I
 
B
 
 subclass of
PI3Ks mediated by the G
 
  
 
 subunits of G-proteins (Stoy-
anov et al., 1995). Studies have suggested a role of phospho-
inositides in the process of receptor internalization. For ex-
ample, deletion of the phosphoinositide binding site from
 
 
 
-arrestin impairs GPCR endocytosis (Gaidarov et al., 1999a),
and the binding of PtdIns (3,4,5) P
 
3
 
 and PtdIns (4,5) P
 
2
 
 to
AP-2 promotes targeting of the receptor-arrestin complex to
clathrin-coated pits (Gaidarov and Keen, 1999).
Recently we have shown a possible involvement of PI3K in
the regulation of 
 
 
 
AR internalization (Naga Prasad et al.,
2001). Considering the potential important role of D-3 phos-
phoinositides in 
 
 
 
AR internalization, we sought to determine:
(a) whether there was a direct physical interaction between
 
 
 
ARK1 and PI3K, and if so, identify the structural domain
responsible for this interaction; (b) whether the interaction of
PI3K with 
 
 
 
ARK1 regulates the translocation PI3K to the ag-
onist-occupied 
 
 
 
AR; and (c) whether the lipid products of
PI3K modulate the internalization of 
 
 
 
ARs.
 
Results
 
Direct physical interaction of PI3K with 
 
 
 
ARK1
 
We postulated that the PIK domain of PI3K (Vanhaese-
broeck et al., 2001), which is characterized by five pairs of
antiparallel helices, might be an important domain to support
protein–protein interactions (Walker et al., 1999). To inves-
tigate whether there is a direct physical interaction between
 
 
 
ARK1 and PI3K, we created PI3K mutants that contained
only the PIK domain (FLAG tagged) or had a deletion of
the PIK domain PI3K
 
 
 
PIK (HA tagged) (Fig. 1 a).
HEK 293 cells were transfected with plasmids contain-
ing the FLAG-PIK and PI3K
 
 
 
PIK-HA cDNAs. PIK and
PI3K
 
 
 
PIK proteins were immunoprecipitated from cell ex-
tracts using monoclonal FLAG and HA antibodies, respec-
tively. After the addition of purified 
 
 
 
ARK1 protein to the
immune complexes, the presence of 
 
 
 
ARK1 was assessed by
immunoblotting for 
 
 
 
ARK1. 
 
 
 
ARK1 was found to associate
with the PIK domain protein and not to full-length PI3K
lacking this domain (PI3K
 
 
 
PIK) (Fig. 1 b). Levels of ex-
pression of PIK and PI3K
 
 
 
PIK proteins were similar (Fig. 1
b, bottom). These data suggest that PI3K and 
 
 
 
ARK1 form
a macromolecular complex within the cell.
To investigate whether there was a direct physical interac-
tion between the PIK domain of PI3K and 
 
 
 
ARK1, GST–
PIK fusion protein was immobilized on sepharose beads and
incubated with purified 
 
 
 
ARK1. Purified 
 
 
 
ARK1 bound
specifically to GST–PIK immobilized beads and not to GST
alone (Fig. 1 c). No difference in the level of GST and
GST–PIK was found (Fig. 1 c, bottom).
Because PI3K
 
 
 
 interacts with the 
 
  
 
 subunits of G-pro-
teins, we tested whether the PIK domain might directly in-
teract with G
 
  
 
, and thus would compete with 
 
 
 
ARK1 for
these subunits. Purified 
 
 
 
ARK1 and GST–PIK fusion pro-
tein immobilized on Sepharose beads were incubated with
purified G
 
  
 
. The beads were washed and recovered proteins
were analyzed by SDS-PAGE followed by immunoblotting
Figure 1.  ARK1 directly interacts 
with the PIK domain of PI3K. 
(a) Schematic representation of full-length 
PI3Kp110  and mutants. ABR adaptor 
binding region, RBD-ras binding domain, 
C2 similar to PLC , which is involved in 
Ca
2 -dependent or -independent 
phospholipid binding, PIK domain 
thought to be involved in protein–protein 
interactions, HA, hemagglutinin tag, 
FLAG, flag peptide tag. (b) HEK 293 
cells cotransfected with plasmids 
containing  ARK1 and FLAG-PIK or 
PI3K PIK cDNAs. FLAG-PIK and 
PI3K PIK were immunoprecipitated 
from cells, fractionated by SDS-PAGE, 
and analyzed by immunoblotting with 
 ARK1 monoclonal antibody.  ARK1 
protein coimmunoprecipitates with 
FLAG-PIK and not with PI3K PIK. 
(c) GST–PIK fusion protein containing 
amino acid residues 535–732 of PI3K  
was produced, which includes the entire 
PIK domain and flanking upstream 10 
amino acids and downstream 7 amino 
acids. Beads with bound GST alone or GST fusion proteins were incubated with purified  ARK1. Beads were washed and bound material was 
run on SDS-PAGE and immunoblotted with  ARK1 monoclonal antibody. Purified  ARK1 was found to bind to the GST–PIK fusion protein, 
whereas no binding was seen with GST alone. (d) PIK domain does not interact with G   subunits of G-protein. Beads with bound GST–PIK 
fusion protein or  ARK1 protein were incubated with purified G   subunits of G-protein. Beads were washed, spun down, and bound material 
separated by SDS-PAGE electrophoresis followed by immunodetection of G . No interaction between G   and the PIK fusion protein was 
found, whereas robust interaction between G   and  ARK1 purified protein was observed. Purified G   was loaded as a positive control. 
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with a G
 
 
 
 polyclonal antibody. Whereas a strong association
of G
 
  
 
 with 
 
 
 
ARK1 was found, no appreciable association
of G
 
  
 
 with the PIK domain was detected (Fig. 1 d). Densi-
tometric quantification showed an 11.5 
 
  
 
1.1-fold greater
binding ability of 
 
 
 
ARK1 to G
 
  
 
 purified proteins com-
pared with the PIK domain.
To test whether overexpression of the PIK domain could
displace 
 
 
 
ARK1 associated PI3K activity in living cells, ex-
periments were performed in HEK 293 cells cotransfected
with plasmids containing the 
 
 
 
ARK1 cDNA (2 
 
 
 
g) and in-
creasing concentrations of the PIK domain cDNA (ranging
from 0 to 6 
 
 
 
g). Cell lysates were immunoprecipitated using
the 
 
 
 
ARK1 monoclonal antibody 48 h after transfection
and 
 
 
 
ARK1 associated PI3K activity was assayed. A robust
 
 
 
ARK1 associated PI3K activity was found in the absence of
PIK domain protein, but this association could be effectively
competed away by increasing the concentration of PIK
cDNA (Fig. 2 a). The maximal reduction of 
 
 ARK1 asso-
ciated PI3K activity occurred when cells were cotrans-
fected with 4  g of PIK cDNA (Fig. 2 b). Furthermore, we
could coimmunoprecipitate FLAG-tagged PIK protein with
 ARK1 monoclonal antibodies in the cotransfected HEK
293 cells (data not depicted).
We next tested whether absence of the PIK domain in an
otherwise intact PI3K molecule would affect the association
of  ARK1 with endogenous PI3K in cells. HEK 293 cells
were cotransfected with plasmids containing cDNAs for
 ARK1 (2  g),  ARK1 plus PIK (4  g), and  ARK1 plus
PI3K PIK (4  g). Cell lysates were immunoprecipitated
with a  ARK1 monoclonal antibody and assayed for the as-
sociated PI3K activity. Expression of PI3K PIK had no ef-
fect on the endogenous  ARK1/PI3K interaction, whereas
overexpression of PIK disrupted this interaction. Treatment
with the selective PI3K inhibitor wortmannin (50 nM), abol-
ished this  ARK associated PI3K activity (Fig. 2, c and d).
Because the PIK domain is shared by all members of the
PI3K family, we wanted to confirm that the  ARK1-asso-
ciated endogenous PI3K activity was contributed by Class
I PI3K. To test this, HEK 293 cells were transfected with
plasmids containing cDNAs for  ARK1 (2  g) or  ARK1
plus PIK (4  g). Cell lysates were immunoprecipitated
with a  ARK1 monoclonal antibody and assayed for the
associated PI3K activity. However, in this experiment
PtdIns-4,5-P2 was used as the substrate instead of PtdIns, as
in vitro, PtdIns-4,5-P2 can be phosphorylated only by
Class I PI3K (Fruman et al., 1998) and not by either the
Class II or Class III PI3K enzymes. As shown in Fig. 2 e,
robust generation of PtdIns-3,4,5-P3, the product of Class
I PI3K catalytic activity, was seen associated with  ARK1
and the coexpression of PIK completely displaced the
Figure 2. Overexpression of the 197 
amino acid PIK domain of PI3K competes 
for endogenous PI3K binding to  ARK1. 
(a) HEK 293 cells were cotransfected with 
 ARK1 and increasing concentrations of 
PIK domain encoding cDNAs.  ARK1 
was immunoprecipitated using  ARK1 
monoclonal antibody and the associated 
PI3K activity was measured. The lipids 
were extracted and run on thin layer 
chromatography plates. Shown is 
representative autoradiograph of 
formation of PIP ( PtdIns-monophosphate). 
Ori, Origin. Mock cells were transfected 
with vector alone. Increasing the quantity 
of PIK cDNA used for expression leads 
to displacement of PI3K activity from 
 ARK1 suggesting PIK protein competes 
out PI3K from  ARK1. Bottom panel 
shows immunoblotting for  ARK1 and 
PIK in cell lysates. (b) Summary results of 
n   5 experiments. *P   0.0005. The 
data was normalized to  ARK1 associated 
PI3K activity in cells transfected with 
 ARK1 only. (c) HEK 293 cells were 
transfected with  ARK1 or  ARK1 and 
PIK or  ARK1 and PI3K PIK encoding 
cDNAs.  ARK1 was immunoprecipitated 
using  ARK1 monoclonal antibody and 
the associated endogenous PI3K activity was assayed. Extracted lipids were run on TLC plates and a representative autoradiograph showing 
the formation of PIP is shown here. Mock cells are transfected with vector alone. PIK overexpression lead to displacement of endogenous 
PI3K activity, whereas PI3K PIK overexpression did not alter  ARK1 associated PI3K activity. Bottom panels show immunoblotting for 
 ARK1, PI3K PIK and PIK in cell lysates. (d) Summary results of n   4 experiments. *P   0.001. The data was normalized to  ARK1 associated 
PI3K activity in cells transfected with  ARK1 only. (e) HEK 293 cells were transfected with  ARK1 or  ARK1 and PIK encoding cDNAs. 
 ARK1 was immunoprecipitated using  ARK1 monoclonal antibody and the associated endogenous PI3K activity was assayed using PIP2 
(PtdIns-4,5-bisphosphate) as a substrate. Extracted lipids were run on TLC plates and the autoradiograph showing the formation of PIP3 
(PtdIns-3,4,5-triphosphate) is presented.  ARK1 transfected cells were treated with wortmannin (Wort) (50 nM) for 15 min before lysis of 
cells. Mock cells were transfected with vector alone. Bottom panel shows immunoblotting for  ARK1 and PIK from cell lysates. Overexpression 
of PIK domain or wortmannin treatment led to significant inhibition in the formation of PIP3.566 The Journal of Cell Biology | Volume 158, Number 3, 2002
Figure 3. Overexpression of PIK 
domain blocks  ARK1 mediated 
translocation of PI3K to the membrane 
and to the  2AR. (a) HEK 293 cells were 
transfected with  ARK1 or  ARK1 and PIK 
encoding cDNAs.  ARK1 was immuno-
precipitated using  ARK1 monoclonal 
antibody from the membrane fraction of 
unstimulated and stimulated (10  M 
isoproterenol for 2 min) cells.  ARK1 
associated PI3K activity was assayed 
from these membranes and extracted 
lipids were separated by thin layer 
chromatography. The significant increase 
in  ARK1 associated PI3K activity found 
in the membrane fraction after agonist 
was completely abolished in presence of 
PIK domain peptide and with wortmannin 
(50 nM) treatment of  ARK1 transfected 
cells (Wort). (b) Membrane fraction of 
cells transfected with  ARK1 or  ARK1 
and PIK encoding cDNAs were 
immunoprecipitated with a  ARK1 
monoclonal antibody and immunoblotted 
for  ARK1. Overexpression of PIK did 
not inhibit  ARK1 translocation to the 
membrane after isoproterenol stimulation. 
(c) HEK 293 cells were transfected with 
 2AR or  2AR and PIK encoding cDNAs. 
The transfected cells were split into 
separate dishes and individually treated 
with 10  M isoproterenol for indicated 
times. Before isoproterenol treatment, a set 
of  2AR-transfected cells were treated with 
wortmannin (Wort) (50 nM). At 
indicated time points FLAG- 2AR was 
immunoprecipitated and the associated 
PI3K activity was measured. Shown is a 
representative autoradiograph of the thin 
layer chromatography plate showing the 
formation of PIP. Lower panel, level of 
expression of  2AR and PIK domain 
protein in cell lysates as assessed by 
immunoblotting.AP-2 recruitment requires D-3 phosphoinositides | Naga Prasad et al. 567
 ARK1 associated PI3K activity (Fig. 2 e). Additionally,
treatment of cells with wortmannin (50 nM) prior to cell
lysis also inhibited the PI3K activity that was coimmuno-
precipitated along with  ARK1 (Fig. 2 e). Taken together,
these data demonstrate that overexpression of the PIK do-
main can disrupt the interaction between  ARK1 and
PI3K, and that the lipid kinase activity belongs to the Class
I PI3K family.
Overexpression of PIK blocks  ARK1-mediated 
translocation of endogenous PI3K
Our results suggest that overexpression of the PIK domain
should block the  ARK1-mediated translocation of PI3K to
the membrane. In order to test this hypothesis, HEK 293
cells were cotransfected with the  ARK1 (2  g),  ARK1,
and PIK domain (4  g) containing plasmids, and endoge-
nous  ARs were stimulated with 10  M isoproterenol for 2
min. Cytosolic and membrane fractions were prepared and
analyzed for  ARK1 associated PI3K activity. After isopro-
terenol stimulation, robust  ARK1-associated PI3K activity
that was wortmannin (50 nM) sensitive could be seen in the
membrane fraction (Fig. 3 a). In contrast, overexpression of
the PIK domain effectively abolished the agonist-induced
translocation of PI3K to the membrane by disrupting the
 ARK1/PI3K interaction. No change in  ARK1 associated
PI3K activity was found in cytosolic fractions after isopro-
terenol stimulation (data not depicted).
To investigate whether  ARK1 recruitment to the mem-
brane would be inhibited in presence of PIK domain pro-
tein, membrane fractions were prepared from the HEK293
cells cotransfected with the  ARK1 (2  g),  ARK1, and
PIK domain (4  g) containing plasmids. As shown in Fig. 3
b, overexpression of PIK had no effect on the membrane re-
cruitment of  ARK1 after isoproterenol (10  M) stimula-
tion. These data show that the overexpression of PIK do-
main protein interrupts the  ARK1/PI3K interaction and
does not affect agonist-dependent  ARK1 translocation to
the membrane.
To test whether disruption of the  ARK1/PI3K interac-
tion would prevent the recruitment of PI3K to activated
 ARs, HEK 293 cells were transfected with plasmids
containing cDNAs encoding FLAG epitope–tagged  2AR
(FLAG- 2AR, 2  g) or FLAG- 2AR (2  g) and PIK do-
main (4  g), and assayed for  2AR associated PI3K activity
after stimulation with 10  M isoproterenol. HEK 293 cells
are known to contain adequate levels of  ARK1 to support
agonist-induced translocation and receptor phosphorylation
(Menard et al., 1997). FLAG-tagged  2ARs were immuno-
precipitated from cell extracts and associated endogenous
PI3K activity measured. Significant FLAG- 2AR–associated
PI3K activity was observed as early as 2 min after agonist
stimulation, with a decline by 5 min in the cells transfected
with  2AR alone (Fig. 3 c). In contrast, no FLAG- 2AR–
associated PI3K activity was found when either the PIK do-
main was overexpressed or the transfected cells were treated
with wortmannin before isoproterenol stimulation (Fig. 3
c). These data indicate that overexpresssion of PIK domain
displaces PI3K from  ARK1 complex, thereby preventing
its recruitment to the agonist-occupied receptor complex.
Attenuation of  2AR sequestration by PIK
Previous studies have suggested a role for PI3K in  2AR in-
ternalization (Naga Prasad et al., 2001). We postulated that
disruption of the endogenous  ARK1/PI3K interaction by
the PIK protein would attenuate  2AR endocytosis. To test
this, agonist-dependent sequestration was studied by [
125I]-
cyanopindolol binding in HEK 293 cells cotransfected with
plasmids containing either the FLAG- 2AR cDNA, or
FLAG- 2AR and FLAG-PIK cDNAs. A significant ( 60%)
attenuation in the rate of  2AR sequestration occurred when
the PIK domain protein was overexpressed (Fig. 4 a). Inter-
estingly, overexpression of PIK domain protein was effective
in attenuating the early processes of  2AR sequestration as
the initial phase (0–5 min) was significantly impaired.
We further evaluated  2AR endocytosis using confocal
microscopy in transfected cells using  2AR tagged with the
YFP ( 2AR-YFP) in the presence and absence of PIK.  2AR
internalization was followed in the same cell after agonist
stimulation. Before agonist, the distribution of  2AR-YFP
was found distinctly at the plasma membrane (Fig. 4 b,
panel 1). After agonist treatment, there was redistribution of
the  2AR-YFP into membrane puncta consistent with entry
into clathrin coated pits (Fig. 4 b, panel 2) (Laporte et al.,
1999). With time, this was followed by the formation of cy-
toplasmic aggregates (Fig. 4 b, panel 3), and then with the
complete loss of membrane fluorescence (Fig. 4 b, panels 3
and 7, arrowheads). In marked contrast, coexpression with
the PIK domain completely prevented redistribution of
 2AR-YFP fluorescence into membrane puncta and blocked
the formation of intracellular aggregates after isoproterenol
stimulation (Fig. 4 b, panels 6 and 8).
To definitively show that only those cells that contained the
PIK domain protein failed to undergo agonist-stimulated  AR
internalization, dual labeling experiments were performed after
cotransfection with plasmids encoding HA tagged  2AR (HA-
 2AR) and PIK–GFP. After isoproterenol stimulation, cells
were fixed and HA- 2AR was visualized by Texas red staining
and PIK was visualized by GFP fluorescence. Cells that
showed restricted distribution of Texas red staining (HA- 2AR
expression) to the membrane (Fig. 4 c, panel 1), also had GFP
fluorescence indicating PIK protein expression (Fig. 4 c, panel
2). In contrast, cells that lacked GFP fluorescence (i.e., PIK
protein expression), showed marked agonist-induced  2AR in-
ternalization (Fig. 4 c, panel 1 and 2, arrowheads) as clearly
seen in the overlay (Fig. 4 c, panel 3, arrowheads).
PI3K is not necessary for  -arrestin recruitment
To test whether PI3K activity was necessary for the recruit-
ment of  -arrestin to the receptor complex, and whether over-
expression of the PIK protein alters agonist-induced receptor
phosphorylation, we used a HEK 293 cell line with stable ex-
pression of both  2AR-HA and  -arrestin2–GFP proteins.
Double stably expressing cells were transfected with the plas-
mid containing FLAG-PIK cDNA and then split in separate
dishes. Confocal microscopy was used to visualize fluores-
cence in cells with 10  M isoproterenol and subsequently
fixed. All cells show  -arrestin2–GFP fluorescence, whereas a
smaller percentage shows Texas red staining of the FLAG
epitope (Fig. 5 a, panels 1 and 2). In the absence of isoproter-568 The Journal of Cell Biology | Volume 158, Number 3, 2002
enol (Fig. 5 a, panels 1 and 2) cells have a cytosolic distribu-
tion of PIK as well as  -arrestin2-GFP. With isoproterenol,
there was marked redistribution of GFP fluorescence to the
membrane, indicating recruitment of  -arrestin to the mem-
brane (Fig. 5 a, panel 3). Importantly, cells that contained
PIK proteins did not affect the membrane recruitment of
 -arrestin (Fig. 5 a, panels 3 and 4, arrowheads), suggesting that
D-3 phosphoinositide molecules are not necessary for arrestin
recruitment to activated receptors.
Overexpression of PIK domain does not inhibit 
clathrin-mediated transferrin uptake or downstream 
signaling of PI3K
To determine whether the overexpression of the PIK domain
in cells nonspecifically affect other clathrin-mediated pro-
cesses, we assessed the ability of transferrin to undergo en-
docytosis. Transferrin receptors are known to constitutively
localize and internalize via clathrin-coated vesicles (van Dam
and Stoorvogel, 2002). HEK 293 cells were transfected with
plasmids encoding PIK–GFP. Transfected cells were incu-
bated with Transferrin–Texas red conjugate at 37 C for 30
min and then fixed. As shown in Fig. 5 b, transferrin uptake
was unaffected by the presence of PIK–GFP (Fig. 5 b, panels
1 and 2), indicating that overexpression of PIK domain does
not inhibit other clathrin mediated processes.
To investigate whether overexpression of PIK domain pro-
tein in cells would alter downstream PI3K signaling, PKB ac-
tivation was measured in HEK 293 cells stably expressing the
PIK domain protein. Cells stably expressing PIK and wild-
type HEK 293 cells were transfected with the plasmid con-
Figure 4. Attenuation of  2AR sequestration upon coexpression of PIK. (a) Agonist-promoted (1  M isoproterenol)  2AR sequestration by 
[
125I]-CYP binding was performed in HEK 293 cells transfected with  2AR and either the empty vector ( ) or PIK ( ) encoding cDNAs over a 
time course of 0–30 min. Receptor expression (fmol/mg of whole-cell protein) was:  2AR   vector, 330   80;  2AR   PIK, 303   51. n   5, 
P   0.0001 versus  2AR. Inset shows expression of PIK protein. (b) Endocytosis of  2AR-YFP in live cells was monitored for 10 min after 
isoproterenol (10  M) stimulation in the absence or presence of PIK domain protein coexpression using confocal microscopy. Panels on the 
left represent cells transfected with the  2AR-YFP alone (panels 1–3 show the same cell monitored at 0, 5, and 10 min after stimulation. Panel 
7 is an example of another cell after 10 min of isoproterenol). Panels on the right represent cell transfected with  2AR-YFP and PIK (panels 4–6 
show the same cell monitored as above). Panel 8 is an example of another cell after 10 min of isoproterenol). In the absence of PIK, isoproterenol 
causes the internalization  2ARs as shown by the formation of distinct cytoplasmic aggregates (arrowheads) and complete loss of membrane 
fluorescence. In contrast, in the presence of PIK domain protein, there is no redistribution of  2AR-YFP after agonist stimulation, indicating 
that the process of receptor endocytosis is completely inhibited. (c) Dual staining was performed in cells transfected with plasmids containing 
HA- 2AR and GFP-PIK cDNAs. After 10 min of 10  M isoproterenol, cells were fixed with 4% paraformaldehyde, stained for HA- 2AR 
receptor with Texas red, and PIK was visualized by GFP fluorescence. Panel 1 shows two cells, one with only membrane distribution of 
HA- 2AR, and another cell with complete redistribution of  2ARs into aggregates (arrowheads). Panel 2, shows that the cell with GFP fluorescence 
(i.e., PIK domain expression) failed to undergo  2AR internalization, whereas the cell not expressing GFP-PIK showed HA- 2AR aggregates. 
Panel 3 is an overlay of panels 1 and 2.AP-2 recruitment requires D-3 phosphoinositides | Naga Prasad et al. 569
taining cDNA for the FLAG- 2AR, and stimulated with var-
ious GPCR or growth factor agonists. Agonist stimulation in
the absence of PIK resulted in a significant increase of pPKB
over mock treatment (Fig. 5, c and d). Importantly, there was
robust PKB activation in the cell line overexpressing the PIK
domain protein (Fig. 5, c and d). These data show that over-
expression of the PIK domain in cells does not interfere with
cellular signaling downstream of PI3K.
Role of D-3 PtdIns in the recruitment of adaptin
Since overexpression of PIK leads to attenuation of  2AR
endocytosis, we wanted to determine whether the  ARK1-
mediated localization of PI3K within the activated receptor
complex is responsible for the generation of D-3 phosphor-
ylated phosphoinositides that promote recruitment of AP-2
to the agonist-occupied receptor. To test this hypothesis,
HEK 293 cells were transfected with FLAG- 2AR or
FLAG- 2AR, and PIK plasmids and then stimulated with
isoproterenol. The FLAG-epitope was immunoprecipitated
from cell extracts and blotted for the associated AP-2 adap-
tin and clathrin proteins. There was a significant increase in
the association of AP-2 adaptin to the agonist-stimulated
receptor within 2–5 min, which returned to basal levels by
10 min (Fig. 6 a). In contrast, overexpression of the PIK
peptide completely abolished the recruitment of adaptin to
the agonist-stimulated  2AR complex (Fig. 6 a). Although
the levels of clathrin that coimmunoprecipitated with the
receptor showed only modest changes after agonist, this ef-
fect appeared to be attenuated in the presence of the PIK
peptide (Fig. 6 a). Similar levels of adaptin, clathrin,  2AR,
Figure 5. Overexpression of PIK neither inhibits  -arrestin2 recruitment to the receptor complex, transferrin uptake, or downstream PI3K 
signaling. (a) Confocal microscopy was used to visualize fluorescence in HEK 293 double stably expressing (HA- 2AR-HA and  -arrestin
2-GFP) cells transfected with the FLAG-PIK plasmid. After stimulation with 10  M isoproterenol for 10 min, cells were fixed and stained with 
Texas red. All cells show  -arrestin2–GFP ( arr2-GFP) fluorescence whereas a smaller percentage show Texas red staining of the FLAG 
epitope. Panels 1 and 2 show that in the absence of isoproterenol, both PIK and  -arrestin2–GFP were distributed in the cytoplasm. Panels 3 
and 4, after the addition of isoproterenol, the presence of PIK domain protein had no effect on the marked redistribution of  -arrestin–GFP 
fluorescence to the membrane (arrowheads). (b) HEK 293 cells were transfected with GFP–PIK (4  g) and plated on to glass-bottom petri 
dishes. Serum-starved cells were incubated with Transferrin (Tf) conjugated to Texas red for 30 min at 37 C. The cells were thoroughly 
washed with PBS and fixed in 4% paraformaldehyde. Fixed cells were visualized using laser scanning confocal microscope. Panel 1 shows 
PIK domain expression in cells as visualized by GFP fluorescence, whereas panel 2 shows the same set of cells that took up Transferrin (Tf) as 
visualized by Texas red. Cells that overexpressed the PIK domain also had robust Transferrin (Tf) uptake. (c) HEK 293 cells or cells stably 
expressing PIK were transfected with  2AR encoding cDNA and treated with various agonists. Clarified lysates (50  g) were immunoblotted 
for phospho-PKB. MOCK, treated with ascorbic acid; IGF, treated with insulin growth factor (10 nM); Car, treated with carbachol (1 mM); 
ISO, treated with isoproterenol dissolved in ascorbic acid (10  M); Cont, positive control for phospho-PKB. (d) Summary results of densitometric 
analysis of phospho-PKB after stimulation by various agonists (n   3–5). The data is represented as fold over basal (MOCK).570 The Journal of Cell Biology | Volume 158, Number 3, 2002
and PIK were observed in the appropriately transfected cells
(Fig. 6 a, bottom).
Because the recruitment of the AP-2 adaptor protein was
inhibited in presence of PIK overexpression, we investigated
whether inhibition of PI3K activity would affect the recruit-
ment of adaptin to the receptor complex. To test this, we
used a HEK 293 cell line with stable expression of FLAG-
 2AR. Cells were treated with LY294002, an inhibitor of
PI3K activity or DMSO as control for 15 min and then
stimulated with isoproterenol. A significant increase in the
association of adaptin protein with the receptor complex is
observed at 5 min in the absence of LY294002, which was
completely blocked with LY294002 pretreatment (Figs. 6, b
and c). These data are consistent with our data showing that
disruption of the  ARK/PI3K interaction with overexpres-
sion of PIK leads to a loss in the receptor associated PI3K ac-
tivity, a reduction in adaptin recruitment, and attenuation
in receptor sequestration
To directly demonstrate that the generation of D-3 PtdIns
phospholipids are important for the recruitment of AP-2
adaptor proteins to the agonist-occupied receptor complex,
the same HEK 293 cells stably expressing FLAG- 2AR
were permeabilized with saponin (Jones et al., 1999) and
then incubated with increasing concentrations of the phos-
phorylated lipids, PtdIns-4,5-P2 and PtdIns-3,4,5-P3. After
stimulation with isoproterenol, FLAG- 2AR was immuno-
precipitated and the immune complexes immunoblotted for
the presence of adaptin. The efficiency of recruitment of
adaptin to the receptor was significantly enhanced in the
presence of PtdIns-3,4,5-P3 compared with a similar con-
centration of PtdIns-4,5-P2 (Figs. 6, d and e). At high con-
centrations of PtdIns-4,5-P2, the preferential effect of
PtdIns-3,4,5-P3 was lost consistent with previous studies
showing that the AP-2 adaptor protein has a higher affinity
for PtdIns-3,4,5-P3 compared to other phosphoinositides
(Gaidarov et al., 1996).
Attenuation of  2AR endocytosis upon inhibition of 
PtdIns-3,4,5-P3 production in cells
To directly test whether the local production of PtdIns-
3,4,5-P3 is required for receptor internalization, we utilized
the lipid phosphatase PTEN (phosphatase and tensin homo-
Figure 6. Generation of D-3 PtdIns are 
necessary for the efficient recruitment 
of adaptin to the  2AR complex. (a) HEK 
293 cells were transfected with FLAG-
 2AR, or FLAG- 2AR and PIK encoding 
cDNAs. Transfected cells were treated 
with isoproterenol (10  M) for 0, 2, 5, and 
10 min  2AR was immunoprecipitated 
using the FLAG epitope from the cells 
lysates and immunoblotted with 
antibodies for AP-2 adaptin protein and 
clathrin. Presence of PIK domain protein 
inhibits AP-2 adaptin association with 
the  2AR complex. Bottom panels show 
expression of  2AR and PIK protein in 
transfected cells and equal quantities 
of adaptin and clathrin loading. IgG, 
represents heavy chain of the 
antibody. C, positive control for clathrin 
and AP2 adaptin proteins. (b) FLAG-
 2AR expressing stable cells were 
treated with LY294002 (a selective PI3K 
inhibitor) for 15 min before isoproterenol 
stimulation. The cells were stimulated 
for 0, 2, 5, and 10 min and  2AR was 
immunoprecipitated using a FLAG 
epitope. Lysates were immunoblotted for 
AP-2 adaptin protein. Presence of 
LY294002 inhibited adaptin recruitment 
to the receptor complex. –LY, untreated 
cells,  LY cells treated with LY294002. 
(c) Summary results of densitometric 
analysis of adaptin recruitment to  2AR 
in presence and absence of LY294002 
(n   7). The data is represented as fold 
over basal. (d) FLAG- 2AR expressing 
stable cells were treated with the 
permeablizing reagent saponin and the 
phospholipids as shown, followed by 
isoproterenol for 5 min. FLAG epitope 
was immunoprecipitated from the cell 
lysates and blotted with adaptin antibodies. The upper panel shows cells treated with phosphatidyinositol-4,5-P2, while lower panel were 
treated with PtdIns-3,4,5-P3. IgG, heavy chain of antibody. (e) Summary results of densitometric analysis of adaptin recruitment to  2AR 
complex in presence of phosphatidyinositol-4,5-P2 (PIP2) or PtdIns-3,4,5-P3 (PIP3) (n   7). Data is represented as fold over basal.AP-2 recruitment requires D-3 phosphoinositides | Naga Prasad et al. 571
logue deleted on chromosome 10) (Vanhaesebroeck et al.,
2001). PTEN is known to use PtdIns-3,4,5-P3 as its primary
substrate converting it to PtdIns-4,5-P2, thus depleting
PtdIns-3,4,5-P3 from the membrane (Vanhaesebroeck et al.,
2001). HEK 293 cells were transfected with plasmids con-
taining cDNAs with either  2AR-YFP or  2AR-YFP plus
PTEN, and  2AR endocytosis was evaluated using laser
scanning confocal microscopy.  2AR internalization was fol-
lowed in the same cell after agonist stimulation. Before ago-
nist, the distribution of  2AR-YFP was found distinctly at
the plasma membrane (Fig. 7 a, panel 1). After agonist stim-
ulation, there was a progressive redistribution of the  2AR-
YFP into membrane puncta, followed by the formation of
cytoplasmic aggregates and complete loss of membrane fluo-
Figure 7. Depletion of D-3 phos-
phatidylinositols leads to attenuation in 
 2AR receptor internalization. 
(a) Endocytosis of  2AR-YFP in live 
cells was monitored for 10 min after 
isoproterenol (10  M) stimulation in the 
absence or presence of PTEN protein 
coexpression using confocal microscopy. 
Panels on the left represent cells 
transfected with the  2AR-YFP alone 
(panels 1–3 show the same cell monitored 
at 0, 5, and 10 min after stimulation). 
Panels on the right represent cell 
transfected with  2AR-YFP and PTEN 
(panels 4–6 show the same cell monitored 
as above). In the absence of PTEN, 
isoproterenol causes the internalization 
 2ARs as shown by the formation of 
distinct cytoplasmic aggregates 
(arrowheads) and complete loss of 
membrane fluorescence. In contrast, in 
the presence of PTEN protein, there is no 
redistribution of  2AR-YFP after agonist 
stimulation, indicating that the process 
of receptor endocytosis is completely 
inhibited. (b) Dual staining was performed 
in cells transfected with plasmids  2AR-
YFP and PTEN cDNAs. After 10 min of 
10  M isoproterenol, cells were fixed 
with 4% paraformaldehyde, stained for 
PTEN using Texas red and  2AR was 
visualized by GFP fluorescence. Panel 1 
(a and b) shows the same cell with intact 
membrane  2AR visualized by GFP 
fluorescence (panel 1 a) and PTEN Texas 
red fluorescence (panel 1 b). Panel 2 
(a and b) shows the cell with complete 
redistribution of  2ARs into aggregrates 
(arrowheads) visualized by GFP 
fluorescence and very little PTEN 
expression as visualized by Texas red 
fluorescence (panel 2 b). Cells from 
panels 1 and 2 are from the same petri 
dish but from different fields of view.572 The Journal of Cell Biology | Volume 158, Number 3, 2002
rescence by 10 min (Fig. 4 b, panels 2 and 3). In contrast,
coexpression of  2ARs with the PTEN completely prevented
the agonist induced redistribution of  2AR-YFP fluores-
cence into membrane puncta and intracellular aggregates
(Fig. 7, panels 4–6).
To show that only those cells that contained the PTEN
failed to undergo agonist-stimulated  AR internalization,
dual labeling experiments were performed in cells co-trans-
fected with plasmids containing  2AR-YFP and PTEN. Af-
ter isoproterenol stimulation cells were fixed and  2AR was
visualized by GFP fluorescence and PTEN expression was
visualized by Texas red staining. Cells that had the restricted
membrane distribution of GFP fluorescence ( 2AR) also
had the Texas red staining (Fig. 7 b, panel 1, a and b). In
contrast, cells that showed  2AR internalization lacked
Texas red staining (PTEN expression) (Fig. 7 b, panel 2, a
and b, arrowheads).
Discussion
In the present investigation, we provide evidence for a direct
protein–protein interaction between PI3K and  ARK1, and
show that the region of the PI3K molecule that provides the
necessary structure for this interaction is the PIK domain.
Moreover, we show that the interaction between PI3K and
 ARK1 is not dependent on G   and that overexpression of
PIK domain competitively displaces PI3K from the  ARK1/
PI3K complex leading to a loss in  ARK1 associated PI3K
activity. Although overexpression of PIK domain protein
disrupts the  ARK1/PI3K interaction, it does not inhibit
the G   mediated translocation of  ARK1 to agonist-occu-
pied receptors or alter other G  -dependent cellular pro-
cesses. Finally, these experiments demonstrate that overex-
pression of the PIK domain markedly attenuates  2AR
endocytosis in the early phase after agonist stimulation, and
suggest that impairing the local production of PtdIns-3,4,5-
P3 lipid molecules within the agonist-occupied receptor
complex affects the recruitment of critical molecules neces-
sary for efficient receptor endocytosis. Furthermore, we
show that overexpression of PTEN, which uses PtdIns-
3,4,5-P3 as a substrate, leads to complete inhibition of  2AR
internalization, providing strong evidence that the local pro-
duction D-3 phosphoinositides by PI3K within the agonist-
occupied receptor complex is required for endocytosis.
Agonist-occupied   ARs are phosphorylated by  ARK1
after translocation of  ARK1 to the membrane (Lefkowitz,
1998). Subsequently, the phosphorylated receptor can bind
with high affinity to  -arrestin (Ferguson et al., 1996),
which then recruits AP-2 adaptor molecules and clathrin;
two required components in the formation of the endocytic
vesicle (Goodman et al., 1996; Laporte et al., 1999, 2000).
Previous studies have shown that the association of adaptor
proteins with clathrin are critical to the formation of the
clathrin lattice complex (Schmid, 1997; Brodsky et al.,
2001). Because the recruitment of AP-2 adaptor proteins are
at least in part regulated by D-3–phosphorylated phospho-
inositides (Gaidarov and Keen, 1999), the generation of
these lipids not only play an important role in targeting of
the agonist-stimulated receptor to the clathrin coated pit,
but are likely important in the initiation/nucleation of the
clathrin lattices at sites of endocytosis. This is consistent
with data from in vitro studies showing that AP-2 in the as-
sembled coat structure (which is very similar to clathrin-
coated pit), binds PtdIns-3,4,5-P3 with greater affinity com-
pared with other phosphoinositides including PtdIns-4,5-P2
(Gaidarov et al., 1996).
Whether the recruitment of AP-2 to agonist-stimulated re-
ceptor initiates the nucleation of a new clathrin-coated pit or
targets the receptor to a preexisting pit, remains controver-
sial. For example, AP180, a neuronal specific clathrin adap-
tor protein needs to bind clathrin and phosphoinositides si-
multaneously to initiate nucleation (Ford et al., 2001), and
the assembled receptor/ -arrestin/AP-2 complex may sub-
serve this role and initiate nucleation of the clathrin-coated
pit (Laporte et al., 2000). In contrast, studies in living cells
have suggested that the targeting of activated GPCRs is to
preexisting clathrin-coated pits (Scott et al., 2002). Further-
more, studies using a clathrin–green fluorescent fusion pro-
tein suggest that clathrin-coated pits form repeatedly at de-
fined sites and the mobility of these pits is limited by the
actin cytoskeleton (Gaidarov et al., 1999b). Studies using re-
ceptor tail like synthetic peptides (crosslinked to UV photo-
reactive molecules) showed enhanced binding to the  2
subunit of the AP-2 complex in presence of D-3 phospho-
inositides, suggesting that phospholipids may provide a
mechanism for increasing the specificity in sorting and clath-
rin coat assembly (Rapoport et al., 1997).
In this study we show that expression of PIK does not
block  -arrestin recruitment to the receptor, nor does it im-
pair the ability of  ARK to phosphorylate activated recep-
tors, as  -arrestin is only recruited to GRK phosphorylated
receptors (Ferguson et al., 1996). Previous studies have
shown that deletion of the phosphoinositide binding do-
main on  -arrestin impairs the formation of clathrin coated
pits, but that this process is not altered by wortmannin treat-
ment (Gaidarov et al., 1999a). This suggests that  -arrestin
can bind PtdIns-4,5-P2, which is present on the plasma
membrane in much greater concentration than PtdIns-
3,4,5-P3. Consistent with these findings is our observation
showing that even in the absence of receptor-associated
PI3K activity, membrane PtdIns-4,5-P2 is sufficient to re-
cruit  -arrestin in an agonist-dependent manner.
Importantly, overexpression of the PIK domain does not
block transferrin uptake, whose receptor constitutively local-
ized within clathrin coated vesicles (van Dam and Stoorvo-
gel, 2002). This suggests that recruitment of PI3K by
 ARK1 to the agonist occupied receptor is a  ARK1 spe-
cific process. Furthermore, overexpression of the PIK do-
main did not affect activation of PKB suggesting a specific
role in displacement of PI3K from  ARK1. Thus, agonist
dependent phosphorylation of PKB in PIK expressing cells
may enable signaling either by direct receptor stimulation or
through transactivation of receptor tyrosine kinases, as
shown for other GPCRs (Kowalski-Chauvel et al., 1996;
Saward and Zahradka, 1997).
To test the hypothesis that the local generation of PtdIns-
3,4,5-P3 is a necessary step for  2AR endocytosis, we per-
formed experiments in cells that had overexpression of
PTEN, a PtdIns-3,4,5-P3 lipid phosphatase. Because PtdIns-
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would be immediately hydrolyzed by PTEN we could deter-
mine the importance for PtdIns-3,4,5-P3 in supporting the
internalization process. The presence of PTEN resulted in
significant inhibition of  2AR endocytosis showing the re-
quirement for PI3K activity within the receptor complex for
effective agonist-induced endocytosis. We postulate that in-
hibition of PtdIns-3,4,5-P3 production within the receptor
complex prevents the effective interaction of various compo-
nents needed for receptor endocytosis particularly, adaptin
leading to an impairment in receptor endocytosis.
The crystal structure of PI3K  shows the PIK domain to
be centrally positioned with a solvent exposed surface suit-
able for protein-protein interactions (Walker et al., 1999).
Therefore, it is possible that other molecules containing a
PIK domain, such as enzymes belonging to the family of
PI3K (all the classes of PI3K), can potentially interact with
 ARK1 depending up the tissue and the abundance of the
various isoforms. This is consistent with our previous data
where we have shown in HEK 293 cells that  ARK1 could
also interact with the PI3K  isoform when overexpressed
(Naga Prasad et al., 2001). Interestingly, it has recently been
shown that another PI3K, the class II PI3K C2 , interacts
with clathrin and regulates clathrin-mediated membrane
trafficking particularly in the process of vesicle uncoating
(Gaidarov et al., 2001). This suggests possible redundancy
for the production of phosphoinositides within the receptor
complex, a finding not surprising considering that receptor
sequestration is a multistep process, highly regulated by
many molecules at different stages (Brodsky et al., 2001).
Taken together, these data show that overexpression of the
PIK domain displaces endogenous PI3K from  ARK1 lead-
ing to impairment of PI3K translocation to the receptor af-
ter agonist stimulation. The loss in receptor associated PI3K
activity impairs the ability of the agonist-occupied receptor/
PI3K complex to generate D-3 phospholipid molecules. We
propose that the products of PI3K play a critical role in de-
termining the dynamics of receptor endocytosis. Agonist-
induced recruitment of class I PI3Ks by  ARK1 to the re-
ceptor complex functions to increase the production of D-3
phospholipid molecules, that in turn regulates the recruit-
ment of AP-2 and cargo (i.e., receptor/ -arrestin complex)
to clathrin-coated pits on the membrane. The generation of
PtdIns-3,4,5-P3 by PI3K within the activated receptor com-
plex promotes more efficient recruitment of AP-2 and recep-
tor sequestration. The rise in the local concentration of
PtdIns-3,4,5-P3 within the receptor complex, which en-
hances the recruitment of AP-2 to the complex, likely plays a
significant role in the initiation/nucleation of new clathrin-
coated pits. The efficiency of clathrin coated pit formation
will depend on the association of the various critical compo-
nents that, in part, are regulated by their affinity to bind
newly generated D-3 phospholipids.
Materials and methods
Cell culture
HEK 293 cells were maintained and transfected as previously described
(Naga Prasad et al., 2001). Cells were harvested 24 h after transfection, re-
plated in triplicate, allowed to grow overnight, and serum starved either
overnight or 2–4 h before agonist stimulation. FLAG-PIK domain expressing
permanent HEK 293 cell line was prepared by selecting cells against Ge-
neticin (Life Technolgies) as described earlier (Laporte et al., 2000). All cells
with stable FLAG-PIK expression showed both diffuse cytoplasmic distribu-
tion of PIK and inhibition of  2AR-YFP internalization as visualized by con-
focal microscopy (unpublished data). HA- 2AR and  -arrestin double stable
cell lines were prepared by selecting the cells against two different antibiot-
ics (Menard et al., 1997). Cell lines with stable expression of FLAG- 2AR, a
gift from Dr. Robert Lefkowitz (Duke University Medical Center, Durham,
NC) and HA- 2AR were used for the confocal experiments.
Plasmid constructs
PIK and PI3K PIK mutants of PI3K were prepared by PCR amplification us-
ing the full-length p110  cDNA as template (Fig. 1 a). The PIK domain was
amplified using Pfu platinum turbo Taq high fidelity enzyme (STRAT-
AGENE) with the 5  primer (5 -TCTCGAGGATCCGCCGCCATGGAC-
TACA AGGACGACGATGATAAGCACCCGATAGCCCTGCCT-3 ) contain-
ing XhoI and BamHI sites for subcloning, followed by Kozak consensus
sequence and a FLAG epitope tag and the 3  primer (5 -GTCGAC-
CTAGTCGTGCAGCATGGC-3 ) containing consensus stop codon with a
SalI site for subcloning. The PCR product was subcloned in zero-blunt
TOPO vector (Invitrogen) and sequence verified for authenticity. After di-
gestion with the restriction enzymes BamHI and SalI, the PIK domain frag-
ment was subcloned into the following expression plasmids: the pRK5
mammalian expression vector, the pGEX-4T1 bacterial expression vector
to generate GST fusion proteins, and the EGFP vector pEGFP-C1.
PI3K PIK was constructed using two PCR reactions that selectively am-
plified upstream and downstream from the PIK domain (Fig. 1 a). PI3K up-
stream from PIK was amplified using the forward primer (5 -TGCGGATC-
CGCCACCATGGAGCTGGAGAACTATAAACAG-3 ) containing a BamHI
site and Kozak consensus sequence, and the reverse primer (5 -TTCTGCTC-
GACCGCGGTCCCCTTCCGG-3 ) containing a SacI site. The region of PI3K
downstream of the PIK domain was amplified using the forward primer (5 -
CTGAGGGGCCGCGGCACAGCCATG-3 ) containing a SacI site and the
reverse primer (5 -ACCCGGGATCCTTAAGCGTAGTCTGGTACGT-3 ) con-
taining a BamHI site and a consensus stop codon. The upstream and down-
stream regions of PI3K were separately subcloned in the zero-blunt TOPO
vector and sequence was verified by dideoxy sequencing. After digestion
with the restriction enzymes BamHI/SacI, a three-fragment ligation was car-
ried with the mammalian expression vector pRK5, to generate the plasmid
containing the PI3K PIK cDNA (Fig. 1 a). The catalytic activity of PI3K PIK
was indistinguishable from wild-type PI3K (unpublished data). The plasmids
containing cDNAs encoding  ARK1, FLAG- 2AR, HA- 2AR, and p110 
have been described previously (Naga Prasad et al., 2001). The PTEN plas-
mid was gift from Dr. Christopher Kontos (Duke University Medical Center).
GST fusion protein expression and pulldown experiments
Plasmid DNAs were transformed in Escherichia coli BL21 cells. Overnight
cultures were grown in LB medium supplemented with ampicillin (100  g/
ml), diluted to an A600 of 0.2 in the same medium, and grown for another
1 h at 37 C. Cultured cells were then induced with 0.1 mM isopropyl-1-thio-
 -D-galactopyranoside for 2 h. Cells were then pelleted, washed once
with PBS, and resuspended in PBS containing 1 mM PMSF, 2 mg/ml
lysozyme, and incubated for 15 min on ice. Cells were lysed by adding
Triton X-100 1%. Solublized cells were incubated with DNase (300 units)
for 15 min on ice and centrifuged at 13,000 rpm for 10 min. Glutathione-
Sepharose beads were added to the supernatant and gently agitated at 4 C
for 2 h. Beads were washed three times with ice-cold PBS containing 1%
Triton X-100 followed by three washes with cold PBS without detergent.
Protein concentration was determined using a DC protein assay kit (Bio-
Rad Laboratories), and the integrity of the fusion protein was analyzed by
SDS-polyacrylamide gel electrophoresis and Coomassie staining.
GST fusion proteins (1–1.5  g) on beads were incubated in 0.5 ml of
binding buffer (10 mM Tris-HCl, pH 7.4, 5 mM EDTA, 0.2% Triton X-100)
for 2 h at 25 C together with purified  ARK1 protein (5  g). The beads
were spun and washed three times with binding buffer followed by three
washes with binding buffer without detergent. The beads were resus-
pended in SDS gel loading buffer and resolved by gel electrophoresis, im-
munoblotting and detection was carried out as described later.
Immobilized purified  ARK1 protein was prepared by incubating
 ARK1 monoclonal antibodies with protein G agarose beads for 1 h at
4 C, followed by the addition of purified  ARK1 protein. Subsequently, 10
 g of purified G   was added to either  ARK1 immobilized beads (5  g),
or the GST–PIK fusion protein beads (5  g), and gently rocked for 45 min
at room temperature. Beads were spun down, washed in binding buffer
 2, and resolved by gel electrophoresis. The presence of G   was de-
tected by immunoblotting with an antibody directed against the G  sub-
unit. Purified G   and  ARK1 were gifts from Dr. Robert Lefkowitz.574 The Journal of Cell Biology | Volume 158, Number 3, 2002
Membrane fractionation
Membrane fractions were prepared as previously described (Naga Prasad
et al., 2001). Briefly, cells were scraped in 1 ml of buffer containing 25 mM
Tris-HCl, pH 7.5, 5 mM EDTA, 5 mM EGTA, 1 mM PMSF, 2  g/ml each
leupeptin and aprotinin, and disrupted by using Dounce homogenizer. In-
tact cells and nuclei were removed by centrifugation at 1,000 g for 5 min. The
supernatant was subjected to centrifugation at 38,000 g for 25 min. The
pellet was resuspended in lysis buffer (1% Nonidet P-40, 10% glycerol,
137 mM NaCl, 20 mM Tris-HCl, pH 7.4, 1 mM sodium orthvanadate, and
2  g/ml each leupeptin and aprotinin) and used as membrane fraction.
Lipid kinase assay
PI3K assays were carried out as previously described (Naga Prasad et al.,
2001). Briefly, cells were lysed in lysis buffer in presence of protease inhib-
itors and membrane and cytosolic fraction was prepared as described
above. 500  g of membrane or cytosolic fraction was used for immuno-
precipitation with either the C5/1 monoclonal antibody directed against
 ARK1 (Choi et al., 1997) or the anti-FLAG M2 monoclonal antibody
(Sigma-Aldrich) in presence of 35  l of protein G-agarose (Life technolo-
gies). The samples were centrifuged at 10,000 rpm for 1 min and sedi-
mented beads were washed once with lysis buffer, thrice with PBS con-
taining 1% NP40 and 100  M sodium-orthovanadate, three times with
100 mM Tris.Cl, pH 7.4, containing 5 mM LiCl and 100  M sodium-ortho-
vanadate, twice with TNE (10 mM Tris.Cl, pH 7.4, 150 mM NaCl, 5 mM
EDTA, and 100  M sodium-orthovandate). The last traces of buffer were
completely removed using the insulin syringe and the pelleted beads were
resuspended in 50  l fresh TNE. To the resuspended pellet 10  l of 100
mM MgCl2 and 10  l of 2 mg/ml PtdIns (20  g) sonicated in TE (10 mM
Tris.Cl, pH 7.4, and 1 mM EDTA) were added. The reactions were started
by adding 10  l of 440  M ATP, 10  Ci 
32p   ATP, and were incubated at
23 C for 10 min with continuous agitation. The reactions were stopped
with 20  l 6N HCl. Extraction of the lipids were done by adding 160  l of
chloroform:methanol (1:1) and the samples were vortexed and centrifuged
at room temperature to separate the phases. 30  l of the lower organic
phase was spotted on to the 200-  silica-coated flexi-TLC plates (Selecto-
flexible; Fischer Scientific) precoated with 1% potassium oxalate. The
spots were allowed to dry and resolved chromatographically with 2N gla-
cial acetic acid:1-propanol (1:1.87). The plates were dried after resolution,
exposed, and the autoradiographic signals were quantitated using Bio-Rad
PhosphoImager. Lipid Preparation: PtdIns (Sigma-Aldrich or Avanti) or
PtdIns-4,5-P2 (Echelon) was dissolved in chloroform at a concentration of
10 mg/ml. 50  l of this stock was dried down in a stream of air in a 1.5-ml
Eppendorf tube. 250  l of TE was added to the Eppendorf to bring the con-
centration to 2 mg/ml. The lipids were suspended by sonicating them in an
ice bath for 5–10 min. Sonicated lipids were then added to each reaction.
PtdIns(4)P (Sigma-Aldrich) or PtdIns-3,4,5-P3 (Echelon) was used as a stan-
dard. The lipid standards were run as a separate lane on the TLC plate to
identify the migration of PIP or PIP3 (Renkonen and Luukkonen, 1976).
TLC plates were stained with iodine to identify the formation lipids prod-
ucts (Renkonen and Luukkonen, 1976).
Immunoblotting and detection
Immunoblotting and detection of  ARK1, FLAG-PIK, PI3K PIK-HA, FLAG-
 2AR, HA- 2AR,  -adaptin, and clathrin were blotted as described previ-
ously (Laporte et al., 1999, 2000). Immunoprecipitating antibodies were
added to 500  g of cell lysate and the immune complexes were washed
and resuspended in gel-loading buffer. Blots were incubated with antibod-
ies recognizing  -adaptin, clathrin heavy chain (BD Transduction Labora-
tories), HA (Roche Molecular Biochemicals), and FLAG (Sigma-Aldrich) at
a 1:2,000 dilution and the  ARK1 monoclonal antibody at a 1:10,000 di-
lution. 50  g of cell lysates were resolved by a 10% SDS-PAGE gel and
transferred to PVDF membrane, phospho-PKB primary antibody was used
at 1:1,000 dilution. Detection was carried out using enhanced chemilumi-
nescence (Amersham Pharmacia Biotech). Densitometric analysis was car-
ried out using Bio-Rad Flouro-S Multiimage software.
Determination of  2AR sequestration in HEK 293 cells by
[
125I]-cyanopindolol binding
 2AR sequestration was performed as previously described (Naga Prasad et
al., 2001). HEK 293 cells were transfected with plasmids containing  2AR
(250 ng) or  2AR (250 ng) and PIK domain (4  g) cDNAs. Total binding
was determined in the presence of 175 pM [
125I]-cyanopindolol (CYP)
alone, 175 pM [
125I]-CYP plus 100 nM CGP12177 was used to determine
internalized receptors and nonspecific binding was determined using 175
pM [
125I]-CYP plus 1  M propranolol (Menard et al., 1997). Sequestration
was calculated as the ratio of (specific receptor binding of [
125I]-CYP in the
presence of CGP12177 and/or specific receptor binding of [
125I]-CYP in
the absence of CGP12177).
Confocal microscopy in living and fixed cells
Confocal microscopy was carried out as previously described (Naga Prasad
et al., 2001). HEK 293 cells were transfected with the plasmids containing
cDNAs encoding either the  2AR-YFP (2  g) or  2AR-YFP (2  g) and PIK
domain (4  g) or  2AR-YFP (2  g) and PTEN (2  g). Cells were plated onto
glass-bottom dishes for observation in the confocal microscope. Live cells
were treated with isoproterenol (10  M) and images were collected se-
quentially over a time course of 0–10 min. For dual staining of  2AR-HA or
FLAG-PIK, cells were fixed in 4% paraformaldehyde in PBS for 30 min after
10 min of 10  M isoproterenol stimulation. Cells were permeabilized with
0.1% Triton X-100 in PBS for 20 min, incubated in 1% BSA in PBS for 1 h.
Cells were washed with PBS and incubated with anti-HA or anti-FLAG
monoclonal antibody (1:250) with 1% BSA in PBS for 1 h. Cells were
washed and incubated with goat anti–mouse IgG conjugated with Texas
red (1:500; Molecular Probes) for 1 h. Samples were visualized using single
sequential line excitation filters at 488 and 568 nm and emission filter sets
at 505–550 nm for GFP detection and 585 for Texas red detection.
Treatment of cells with phospholipids
Modification of a previously described method was used to vary the con-
centration of D-3 phospholipids in living cells (Jones et al., 1999). Briefly,
one of the synthetic phospholipids DiC16 PtdIns-3-P, DiC16 PtdIns-4,5-P2,
or DiCPtdIns-3,4,5-P3 (AVANTI), was mixed with phosphatidylcholine and
phosphoinositol (Sigma-Aldrich) at a 1:100:100 ratio and dried under N2.
Phospholipids were then re-suspended in 10 mM Hepes, pH 7.4, containing
1 mM EDTA and sonicated. Cells were treated with Saponin (0.04 mg/ml) in
serum-free medium along with the vesicles containing the phospholipids at
given concentration of PtdIns-3-P or PtdIns-4,5-P2 or PtdIns-3,4,5-P3 for 10
min at 25 C. Cells were then treated with isoproterenol (10  M) for 5 min at
37 C, then lysed for immunoprecipitation experiments with a buffer con-
taining 0.8% Triton X-100, 20 mM tris-HCl, pH 7.4, 300 mM NaCl, 1 mM
EDTA, 20% glycerol, 0.1 PMSF, 10  g/ml leupeptin and aprotinin.
Transferrin uptake
Transferrin uptake was carried out as described previously (van Dam and
Stoorvogel, 2002). Briefly, HEK 293 cells were transfected with GFP-PIK (4
 g). 24 h after transfection, the cells were split into six glass-bottom petri
dishes (Mat Tek Corporation). The following day the cells were serum
starved for 1 h before transferrin treatment. Transferrin–Texas red conju-
gate was added to the cells at a final concentration of 33  g/ml and incu-
bated at 37 C for 30 min. After 30 min the cells were washed with PBS and
fixed in 4% paraformaldehyde. Confocal microscopy was carried out on
these cells as described earlier above.
Statistical analysis
Data are expressed as mean   SEM. Statistical comparisons were per-
formed using an unpaired Student’s t test and analysis of variance where
appropriate. Results for the  2AR sequestration by CYP binding was ana-
lyzed using Graph-pad prism.
This work was supported in part by National Institutes of Health grants
HL56687 and HL61558 (H.A. Rockman), the Burroughs Wellcome Fund
(H.A. Rockman), and an AHA Postdoctoral fellowship form the American
Heart Association, Mid-Atlantic Affiliate (S.V. Naga Prasad). H.A. Rock-
man is a recipient of a Burroughs Wellcome Fund Clinical Scientist Award
in Translational Research. M.G. Caron is an Investigator of the Howard
Hughes Medical Institute.
Submitted: 22 February 2002
Revised: 12 June 2002
Accepted: 12 June 2002
References
Brodsky, F.M., C.Y. Chen, C. Knuehl, M.C. Towler, and D.E. Wakeham. 2001.
Biological basket weaving: formation and function of clathrin-coated vesi-
cles. Annu. Rev. Cell Dev. Biol. 17:517–568.
Choi, D.J., W.J. Koch, J.J. Hunter, and H.A. Rockman. 1997. Mechanism of
beta-adrenergic receptor desensitization in cardiac hypertrophy is increased
beta-adrenergic receptor kinase. J. Biol. Chem. 272:17223–17229.
Czech, M.P. 2000. PIP2 and PIP3: complex roles at the cell surface. Cell. 100:603–
606.AP-2 recruitment requires D-3 phosphoinositides | Naga Prasad et al. 575
Ferguson, S.S., W.E. Downey III, A.M. Colapietro, L.S. Barak, L. Menard, and
M.G. Caron. 1996. Role of beta-arrestin in mediating agonist-promoted G
protein-coupled receptor internalization. Science. 271:363–366.
Ford, M.G., B.M. Pearse, M.K. Higgins, Y. Vallis, D.J. Owen, A. Gibson, C.R.
Hopkins, P.R. Evans, and H.T. McMahon. 2001. Simultaneous binding of
PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices
on membranes. Science. 291:1051–1055.
Fruman, D.A., R.E. Meyers, and L.C. Cantley. 1998. Phosphoinositide kinases.
Annu. Rev. Biochem. 67:481–507.
Gaidarov, I., Q. Chen, J.R. Falck, K.K. Reddy, and J.H. Keen. 1996. A functional
phosphatidylinositol 3,4,5-trisphosphate/phosphoinositide binding domain
in the clathrin adaptor AP-2 alpha subunit. Implications for the endocytic
pathway. J. Biol. Chem. 271:20922–20929.
Gaidarov, I., and J.H. Keen. 1999. Phosphoinositide-AP-2 interactions required for
targeting to plasma membrane clathrin-coated pits. J. Cell Biol. 146:755–764.
Gaidarov, I., J.G. Krupnick, J.R. Falck, J.L. Benovic, and J.H. Keen. 1999a. Arres-
tin function in G protein-coupled receptor endocytosis requires phospho-
inositide binding. EMBO J. 18:871–881.
Gaidarov, I., F. Santini, R.A. Warren, and J.H. Keen. 1999b. Spatial control of
coated-pit dynamics in living cells. Nat. Cell Biol. 1:1–7.
Gaidarov, I., M.E. Smith, J. Domin, and J.H. Keen. 2001. The class II phospho-
inositide 3-kinase C2alpha is activated by clathrin and regulates clathrin-
mediated membrane trafficking. Mol. Cell. 7:443–449.
Goodman, O.B., Jr., J.G. Krupnick, F. Santini, V.V. Gurevich, R.B. Penn, A.W.
Gagnon, J.H. Keen, and J.L. Benovic. 1996. Beta-arrestin acts as a clathrin
adaptor in endocytosis of the beta2-adrenergic receptor. Nature. 383:447–450.
Johnson, M. 1998. The beta-adrenoceptor. Am. J. Respir. Crit. Care Med. 158:
S146–S153.
Jones, S.M., R. Klinghoffer, G.D. Prestwich, A. Toker, and A. Kazlauskas. 1999.
PDGF induces an early and a late wave of PI 3-kinase activity, and only the
late wave is required for progression through G1. Curr. Biol. 9:512–521.
Koch, W.J., R.J. Lefkowitz, and H.A. Rockman. 2000. Functional consequences of al-
tering myocardial adrenergic receptor signaling. Annu. Rev. Physiol. 62:237–260.
Kowalski-Chauvel, A., L. Pradayrol, N. Vaysse, and C. Seva. 1996. Gastrin stimu-
lates tyrosine phosphorylation of insulin receptor substrate 1 and its associa-
tion with Grb2 and the phosphatidylinositol 3-kinase. J. Biol. Chem. 271:
26356–26361.
Laporte, S.A., R.H. Oakley, J.A. Holt, L.S. Barak, and M.G. Caron. 2000. The in-
teraction of beta-arrestin with the AP-2 adaptor is required for the clustering
of beta 2-adrenergic receptor into clathrin-coated pits. J. Biol. Chem. 275:
23120–23126.
Laporte, S.A., R.H. Oakley, J. Zhang, J.A. Holt, S.S. Ferguson, M.G. Caron, and
L.S. Barak. 1999. The beta2-adrenergic receptor/betaarrestin complex re-
cruits the clathrin adaptor AP-2 during endocytosis. Proc. Natl. Acad. Sci.
USA. 96:3712–3717.
Lefkowitz, R.J. 1998. G protein-coupled receptors. III. New roles for receptor ki-
nases and beta-arrestins in receptor signaling and desensitization. J. Biol.
Chem. 273:18677–18680.
Martin, T.F. 1998. Phosphoinositide lipids as signaling molecules: common
themes for signal transduction, cytoskeletal regulation, and membrane traf-
ficking. Annu. Rev. Cell Dev. Biol. 14:231–264.
Menard, L., S.S. Ferguson, J. Zhang, F.T. Lin, R.J. Lefkowitz, M.G. Caron, and
L.S. Barak. 1997. Synergistic regulation of beta2-adrenergic receptor seques-
tration: intracellular complement of beta-adrenergic receptor kinase and beta-
arrestin determine kinetics of internalization. Mol. Pharmacol. 51:800–808.
Naga Prasad, S.V., L.S. Barak, A. Rapacciuolo, M.G. Caron, and H.A. Rockman.
2001. Agonist-dependent recruitment of phosphoinositide 3-kinase to the
membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestra-
tion. J. Biol. Chem. 276:18953–18959.
Pitcher, J.A., N.J. Freedman, and R.J. Lefkowitz. 1998. G protein-coupled recep-
tor kinases. Annu. Rev. Biochem. 67:653–692.
Rameh, L.E., and L.C. Cantley. 1999. The role of phosphoinositide 3-kinase lipid
products in cell function. J. Biol. Chem. 274:8347–8350.
Rapoport, I., M. Miyazaki, W. Boll, B. Duckworth, L.C. Cantley, S. Shoelson, and
T. Kirchhausen. 1997. Regulatory interactions in the recognition of en-
docytic sorting signals by AP-2 complexes. EMBO J. 16:2240–2250.
Renkonen, O., and A. Luukkonen. 1976. Thin-Layer Chromatography of Phos-
pholipids and Glycolipids. Marcel Dekker, Inc., New York. 2–54.
Rockman, H.A., W.J. Koch, and R.J. Lefkowitz. 2002. Seven-transmembrane-
spanning receptors and heart function. Nature. 415:206–212.
Sato, T.K., M. Overduin, and S.D. Emr. 2001. Location, location, location: mem-
brane targeting directed by PX domains. Science. 294:1881–1885.
Saward, L., and P. Zahradka. 1997. Angiotensin II activates phosphatidylinositol
3-kinase in vascular smooth muscle cells. Circ. Res. 81:249–257.
Schmid, S.L. 1997. Clathrin-coated vesicle formation and protein sorting: an inte-
grated process. Annu. Rev. Biochem. 66:511–548.
Scott, M.G.H., A. Benmerah, O. Muntaner, and S. Marullo. 2002. Recruitment of
activated G protein-coupled receptors to pre-existing clathrin-coated pits in
living cells. J. Biol. Chem. 277:3552–3559.
Stoyanov, B., S. Volinia, T. Hanck, I. Rubio, M. Loubtchenkov, D. Malek, S.
Stoyanova, B. Vanhaesebroeck, R. Dhand, B. Nurnberg, et al. 1995. Clon-
ing and characterization of a G protein-activated human phosphoinositide-3
kinase. Science. 269:690–693.
van Dam, E.M., and W. Stoorvogel. 2002. Dynamin-dependent transferrin recep-
tor recycling by endosome-derived clathrin-coated vesicles. Mol. Biol. Cell.
13:169–182.
Vanhaesebroeck, B., S.J. Leevers, K. Ahmadi, J. Timms, R. Katso, P.C. Driscoll, R.
Woscholski, P.J. Parker, and M.D. Waterfield. 2001. Synthesis and function
of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70:535–602.
Walker, E.H., O. Perisic, C. Ried, L. Stephens, and R.L. Williams. 1999. Struc-
tural insights into phosphoinositide 3-kinase catalysis and signalling. Nature.
402:313–320.